<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Enlivex Therapeutics Ltd. (ENLV) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/enlv/filings</link>
    <description>Latest company filings for Enlivex Therapeutics Ltd. (ENLV) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Sun, 12 Jul 2026 11:33:47 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/enlv/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026061765/ea0292428-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-061765</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2026-05-28.]]></description>
      <pubDate>Thu, 28 May 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026061243/ea0292240-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-061243</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2026-05-27.]]></description>
      <pubDate>Wed, 27 May 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026058130/ea0291229-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-058130</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2026-05-18.]]></description>
      <pubDate>Mon, 18 May 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026057782/ea0290815-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-057782</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 424B3]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026050966/ea0287961-424b3_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-050966</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 424B3 (424B3) on 2026-05-01.]]></description>
      <pubDate>Fri, 01 May 2026 12:00:00 GMT</pubDate>
      <category>424B3</category>
    </item>
    <item>
      <title><![CDATA[ENLV: EFFECT]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/999999999526001413/xslEFFECTX01/primary_doc.xml</link>
      <guid isPermaLink="false">9999999995-26-001413</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a EFFECT (EFFECT) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>EFFECT</category>
    </item>
    <item>
      <title><![CDATA[ENLV: F-3]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026046177/ea0286920-f3_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-046177</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a F-3 (F-3) on 2026-04-21.]]></description>
      <pubDate>Tue, 21 Apr 2026 12:00:00 GMT</pubDate>
      <category>F-3</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026045892/ea028706001-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-045892</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2026-04-21.]]></description>
      <pubDate>Tue, 21 Apr 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026041277/ea0285376-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-041277</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2026-04-08.]]></description>
      <pubDate>Wed, 08 Apr 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026034383/ea028345301-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-034383</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2026-03-26.]]></description>
      <pubDate>Thu, 26 Mar 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 20-F]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026033857/ea0282960-20f_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-033857</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 20-F (20-F) on 2026-03-25.]]></description>
      <pubDate>Wed, 25 Mar 2026 12:00:00 GMT</pubDate>
      <category>20-F</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026033853/ea0283248-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-033853</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2026-03-25.]]></description>
      <pubDate>Wed, 25 Mar 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026033240/ea0283045-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-033240</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2026-03-24.]]></description>
      <pubDate>Tue, 24 Mar 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026032634/ea0282900-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-032634</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2026-03-23.]]></description>
      <pubDate>Mon, 23 Mar 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 424B3]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026032340/ea028279301-424b3_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-032340</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 424B3 (424B3) on 2026-03-20.]]></description>
      <pubDate>Fri, 20 Mar 2026 12:00:00 GMT</pubDate>
      <category>424B3</category>
    </item>
    <item>
      <title><![CDATA[ENLV: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026029605/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001213900-26-029605</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a New insider ownership (3) on 2026-03-18.]]></description>
      <pubDate>Wed, 18 Mar 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[ENLV: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026029601/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001213900-26-029601</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a New insider ownership (3) on 2026-03-18.]]></description>
      <pubDate>Wed, 18 Mar 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[ENLV: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026029599/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001213900-26-029599</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a New insider ownership (3) on 2026-03-18.]]></description>
      <pubDate>Wed, 18 Mar 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[ENLV: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026029589/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001213900-26-029589</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a New insider ownership (3) on 2026-03-18.]]></description>
      <pubDate>Wed, 18 Mar 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[ENLV: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026029579/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001213900-26-029579</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a New insider ownership (3) on 2026-03-18.]]></description>
      <pubDate>Wed, 18 Mar 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[ENLV: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026029575/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001213900-26-029575</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a New insider ownership (3) on 2026-03-18.]]></description>
      <pubDate>Wed, 18 Mar 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[ENLV: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026029566/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001213900-26-029566</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a New insider ownership (3) on 2026-03-18.]]></description>
      <pubDate>Wed, 18 Mar 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[ENLV: Employee stock plan (S-8)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026027685/ea0281372-s8_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-027685</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a Employee stock plan (S-8) on 2026-03-13.]]></description>
      <pubDate>Fri, 13 Mar 2026 12:00:00 GMT</pubDate>
      <category>S-8</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026019019/ea0277907-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-019019</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2026-02-23.]]></description>
      <pubDate>Mon, 23 Feb 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026013938/ea0276174-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-013938</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2026-02-10.]]></description>
      <pubDate>Tue, 10 Feb 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026012548/ea0275705-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-012548</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2026-02-05.]]></description>
      <pubDate>Thu, 05 Feb 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026007471/ea0273964-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-007471</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2026-01-26.]]></description>
      <pubDate>Mon, 26 Jan 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026006926/ea0273631-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-006926</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2026-01-23.]]></description>
      <pubDate>Fri, 23 Jan 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026001969/ea027203401-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-001969</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2026-01-07.]]></description>
      <pubDate>Wed, 07 Jan 2026 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 424B3]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390026001806/ea0271362-424b3_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-26-001806</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 424B3 (424B3) on 2026-01-06.]]></description>
      <pubDate>Tue, 06 Jan 2026 12:00:00 GMT</pubDate>
      <category>424B3</category>
    </item>
    <item>
      <title><![CDATA[ENLV: EFFECT]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/999999999526000037/xslEFFECTX01/primary_doc.xml</link>
      <guid isPermaLink="false">9999999995-26-000037</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a EFFECT (EFFECT) on 2026-01-02.]]></description>
      <pubDate>Fri, 02 Jan 2026 12:00:00 GMT</pubDate>
      <category>EFFECT</category>
    </item>
    <item>
      <title><![CDATA[ENLV: Company correspondence (CORRESP)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390025126361/filename1.htm</link>
      <guid isPermaLink="false">0001213900-25-126361</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a Company correspondence (CORRESP) on 2025-12-30.]]></description>
      <pubDate>Tue, 30 Dec 2025 12:00:00 GMT</pubDate>
      <category>CORRESP</category>
    </item>
    <item>
      <title><![CDATA[ENLV: SEC correspondence (UPLOAD)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000000000025011873/filename1.pdf</link>
      <guid isPermaLink="false">0000000000-25-011873</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a SEC correspondence (UPLOAD) on 2025-12-29.]]></description>
      <pubDate>Mon, 29 Dec 2025 12:00:00 GMT</pubDate>
      <category>UPLOAD</category>
    </item>
    <item>
      <title><![CDATA[ENLV: F-3]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390025125374/ea0270663-f3_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-25-125374</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a F-3 (F-3) on 2025-12-23.]]></description>
      <pubDate>Tue, 23 Dec 2025 12:00:00 GMT</pubDate>
      <category>F-3</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390025123303/ea0270119-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-25-123303</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2025-12-18.]]></description>
      <pubDate>Thu, 18 Dec 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390025118074/ea0268402-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-25-118074</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2025-12-04.]]></description>
      <pubDate>Thu, 04 Dec 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390025115075/ea0267296-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-25-115075</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2025-11-26.]]></description>
      <pubDate>Wed, 26 Nov 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390025113881/ea0266870-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-25-113881</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2025-11-24.]]></description>
      <pubDate>Mon, 24 Nov 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390025113879/ea0266872-424b5_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-25-113879</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a Prospectus supplement (424B5) on 2025-11-24.]]></description>
      <pubDate>Mon, 24 Nov 2025 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390025113831/ea0266869-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-25-113831</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2025-11-24.]]></description>
      <pubDate>Mon, 24 Nov 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390025111782/ea0266091-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-25-111782</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2025-11-18.]]></description>
      <pubDate>Tue, 18 Nov 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390025110920/ea0265573-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-25-110920</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2025-11-14.]]></description>
      <pubDate>Fri, 14 Nov 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390025108243/ea0264726-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-25-108243</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2025-11-10.]]></description>
      <pubDate>Mon, 10 Nov 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390025091674/ea0258628-01.htm</link>
      <guid isPermaLink="false">0001213900-25-091674</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2025-09-25.]]></description>
      <pubDate>Thu, 25 Sep 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390025086674/ea0256928-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-25-086674</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2025-09-11.]]></description>
      <pubDate>Thu, 11 Sep 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390025085857/ea0256508-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-25-085857</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2025-09-09.]]></description>
      <pubDate>Tue, 09 Sep 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390025082585/ea0254617-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-25-082585</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2025-08-29.]]></description>
      <pubDate>Fri, 29 Aug 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390025077718/ea0253652-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-25-077718</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2025-08-18.]]></description>
      <pubDate>Mon, 18 Aug 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390025077714/ea0253587-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-25-077714</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2025-08-18.]]></description>
      <pubDate>Mon, 18 Aug 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
    <item>
      <title><![CDATA[ENLV: 6-K]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1596812/000121390025076091/ea0253151-6k_enlivex.htm</link>
      <guid isPermaLink="false">0001213900-25-076091</guid>
      <description><![CDATA[Enlivex Therapeutics Ltd. filed a 6-K (6-K) on 2025-08-14.]]></description>
      <pubDate>Thu, 14 Aug 2025 12:00:00 GMT</pubDate>
      <category>6-K</category>
    </item>
  </channel>
</rss>